{
    "clinical_study": {
        "@rank": "164894", 
        "arm_group": [
            {
                "arm_group_label": "Desflurane", 
                "arm_group_type": "Experimental", 
                "description": "Desflurane inhalation at 1-2 MAC during surgery."
            }, 
            {
                "arm_group_label": "Propofol", 
                "arm_group_type": "Active Comparator", 
                "description": "5-8 mg/kg/hr infusion during surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "This study examines pharmacological preconditioning and post conditioning of desflurane by\n      comparing cardiac troponin release in patients receiving either desflurane or propofol for\n      the aortic valve surgery."
        }, 
        "brief_title": "Desflurane-induced Myocardial Protection", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Valve Stenosis", 
        "condition_browse": {
            "mesh_term": "Aortic Valve Stenosis"
        }, 
        "detailed_description": {
            "textblock": "Patients scheduled for aortic valve replacement with use of cardiopulmonary bypass are\n      included in the study. Patients are assigned to desflurane group (Des) or propofol group\n      (Prop). Des receives desflurane (1-2 MAC) inhalation between the induction of anesthesia and\n      cardiopulmonary bypass (CPB). After the induction of CPB, the anesthesia in Des is switched\n      to a total intravenous anesthesia (TIVA) with propofol. Prop receives a TIVA during the\n      surgery. All patients receive a continuous infusion of remifentanil. Biomarker of myocardial\n      damage troponin I is examined at 4 points; T1: after the induction of anesthesia, T2:\n      arrival at ICU, T3: 12 hours after the ICU arrival, T4: 24 hours after the ICU arrival, T5:\n      third post operative day (3POD)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for aortic valve replacement with use of cardiopulmonary bypass.\n\n        Exclusion Criteria:\n\n          -  Patients younger than 20 years old.\n\n          -  Recent myocardial infarction (within 1 year).\n\n          -  Renal dysfunction (GFR less than 50ml/min).\n\n          -  Known allergy to study drugs including propofol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019797", 
            "org_study_id": "Desflurane"
        }, 
        "intervention": {
            "arm_group_label": [
                "Desflurane", 
                "Propofol"
            ], 
            "description": "Patients are assigned to desflurane group (Des) or propofol group (Prop). Des receives desflurane (1-2 MAC) inhalation between the induction of anesthesia and before cardiopulmonary bypass (CPB). After the induction of CPB, the anesthesia in Des is switched to a total intravenous anesthesia (TIVA) with propofol. Prop receives a propofol during the surgery.", 
            "intervention_name": "Desflurane", 
            "intervention_type": "Drug", 
            "other_name": "SUPRANE"
        }, 
        "intervention_browse": {
            "mesh_term": "Desflurane"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "aortic valve replacement", 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "contact": {
                "email": "nbyk@a5.keio.jp", 
                "last_name": "Nobuyuki Katori, M.D.", 
                "phone": "81-3-3353-1211", 
                "phone_ext": "61608"
            }, 
            "contact_backup": {
                "email": "morisaki@z8.keio.jp", 
                "last_name": "Hiroshi Morisaki, M.D.", 
                "phone": "81-3-3353-1211", 
                "phone_ext": "61608"
            }, 
            "facility": {
                "address": {
                    "city": "Tokyo", 
                    "country": "Japan", 
                    "zip": "160-8582"
                }, 
                "name": "Keio University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Hiroshi Morisaki, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Nobuyuki Katori, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Desflurane-induced Myocardial Protection in Aortic Valve Surgery: A Pilot Study", 
        "overall_contact": {
            "email": "nbyk@a5.keio.jp", 
            "last_name": "Nobuyuki Katori, M.D.", 
            "phone": "81-3-3353-1211", 
            "phone_ext": "61608"
        }, 
        "overall_contact_backup": {
            "email": "morisaki@z8.keio.jp", 
            "last_name": "Hiroshi Morisaki, M.D.", 
            "phone": "81-3-3353-1211", 
            "phone_ext": "61608"
        }, 
        "overall_official": {
            "affiliation": "Keio University, School of Medicine", 
            "last_name": "Makoto Suematsu, M.D., Ph.D", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Troponin I", 
            "safety_issue": "No", 
            "time_frame": "up to 3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019797"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Keio University", 
            "investigator_full_name": "Nobuyuki Katori", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Length of ICU stay, Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "up to 2 months after the surgery"
            }, 
            {
                "measure": "Acute myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "up to 7 days"
            }
        ], 
        "source": "Keio University", 
        "sponsors": {
            "collaborator": {
                "agency": "Baxter Healthcare Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Nobuyuki Katori", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}